Lv2
128 积分 2023-03-08 加入
Subcutaneous panniculitis-like T-cell lymphoma and follicular lymphoma emerging during immune checkpoint inhibitor therapy
2天前
待确认
T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategies
2天前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
2天前
已完结
Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to Cyclosporine
2天前
已完结
Secondary primary malignancies after CD‐19 directed CAR‐T‐cell therapy in lymphomas: A report from the Italian CART‐SIE study
2天前
已关闭
Secondary Malignancies of Chimeric Antigen Receptor T-cell Therapy: A Multidimensional Analysis of Mechanisms, Risk Factors, and Treatment Strategies
2天前
已完结
Isolated oral CAR+ T cell lymphoma after tisagenlecleucel
2天前
已完结
T-Cell Lymphoma From CAR T-Cell Therapy—A New Safety Notice
2天前
已完结
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
2天前
已完结
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53
2天前
已完结
皖公网安备34019202002308
